Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 4

Research Article

Clinical Study on the Prevention of Oxaliplatin-Induced Neurotoxicity with Guilongtongluofang: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Table 4

Adverse events in the trial group and the control group.

Adverse eventsTrial group ( , %)
( )
Control group ( , %)
( )
value

Anemia
 Grades 1-27 (11.7)8 (13.3)0.78
 Grades 3-400
Neutropenia
 Grades 1-214 (23.3)13 (21.7)0.92
 Grades 3-47 (11.7)6 (10.0)
Thrombocytopenia
 Grades 1-210 (16.7)9 (15.0)0.80
 Grades 3-400
Nausea
 Grades 1-218 (30.0)20 (33.3)0.69
 Grades 3-400
Vomiting
 Grades 1-214 (23.3)16 (26.7)0.67
 Grades 3-400
Diarrhea
 Grades 1-212 (20.0)13 (21.7)0.56
 Grades 3-41 (1.7)3 (5.0)
Stomatitis
 Grades 1-212 (20.0)11 (18.3)0.81
 Grades 3-400

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.